Synthesis, Biological Evaluation, and Computational Insights of Organyltellurium(IV) Complexes With 5‐Substituted Furan Ligand DOI Open Access
Nidhi Antil, Mahak Dalal, Binesh Kumar

et al.

Applied Organometallic Chemistry, Journal Year: 2025, Volume and Issue: 39(4)

Published: March 20, 2025

ABSTRACT Organyltellurium(IV) complexes have attracted significant attention due to their structural versatility and promising biological applications. In this study, a series of novel organyltellurium(IV) with 5‐substituted furan‐based ligands were designed, synthesized, evaluated for antioxidant, antimicrobial, anti‐inflammatory properties. The synthesized compounds characterized by ultraviolet–visible (UV–Vis), FT‐IR, 1 H‐NMR, 13 C‐NMR, mass spectrometry, molar conductance, elemental analysis, powder X‐ray diffraction thermal analyses which states that the bidentate Schiff base ligand (MeF4AP) coordinated via oxygen nitrogen atom tellurium giving hexa‐coordinated tellurium(IV) complexes. silico studies, including molecular docking, density functional theory (DFT) calculations, MESP ADME profiling provided insights into stability, electronic properties, pharmacokinetic potential. DPPH BSA assays revealed 3c (IC₅₀ = 4.95 ± 0.02 μM), 3b 7.12 0.07 μM 3f 4.14 0.11 μM) exhibited highest antioxidant activity compared ligand. Notably, complex MIC 0.20 mg/mL against Candida albicans nearly twice as potent standard drug griseofulvin (MIC 0.50 mg/mL). FMO studies supports more bioactivity base. displayed most reactive regions. strong correlation between computational predictions in vitro results highlights potential these multifunctional therapeutic candidates pave way further exploration biomedical

Language: Английский

Synthesis, Biological Evaluation, and Computational Insights of Organyltellurium(IV) Complexes With 5‐Substituted Furan Ligand DOI Open Access
Nidhi Antil, Mahak Dalal, Binesh Kumar

et al.

Applied Organometallic Chemistry, Journal Year: 2025, Volume and Issue: 39(4)

Published: March 20, 2025

ABSTRACT Organyltellurium(IV) complexes have attracted significant attention due to their structural versatility and promising biological applications. In this study, a series of novel organyltellurium(IV) with 5‐substituted furan‐based ligands were designed, synthesized, evaluated for antioxidant, antimicrobial, anti‐inflammatory properties. The synthesized compounds characterized by ultraviolet–visible (UV–Vis), FT‐IR, 1 H‐NMR, 13 C‐NMR, mass spectrometry, molar conductance, elemental analysis, powder X‐ray diffraction thermal analyses which states that the bidentate Schiff base ligand (MeF4AP) coordinated via oxygen nitrogen atom tellurium giving hexa‐coordinated tellurium(IV) complexes. silico studies, including molecular docking, density functional theory (DFT) calculations, MESP ADME profiling provided insights into stability, electronic properties, pharmacokinetic potential. DPPH BSA assays revealed 3c (IC₅₀ = 4.95 ± 0.02 μM), 3b 7.12 0.07 μM 3f 4.14 0.11 μM) exhibited highest antioxidant activity compared ligand. Notably, complex MIC 0.20 mg/mL against Candida albicans nearly twice as potent standard drug griseofulvin (MIC 0.50 mg/mL). FMO studies supports more bioactivity base. displayed most reactive regions. strong correlation between computational predictions in vitro results highlights potential these multifunctional therapeutic candidates pave way further exploration biomedical

Language: Английский

Citations

0